The Effects of Strawberries on Blood Pressure in Postmenopausal Women
Daily Incorporation of Strawberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Prehypertension
1 other identifier
interventional
60
1 country
1
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death in the US. Statistics show that approximately 91% of individuals with CVD have vascular dysfunction. Hypertension is a major modifiable risk factor for CVD and approximately 60% of adults in the US are pre-hypertensive and hypertensive. In addition, the prevalence of hypertension is associated with aging in both genders; however, the increase in blood pressure (BP) in women after menopause exceeds that of men. The development of effective and safe strategies to improve vascular function is of significance as it can have a great impact on quality of life, productivity and economic burden for the affected populations. One such alternative would be to introduce into the diet food sources that are rich in naturally occurring bioactive compounds. Thus, the long-term goal of the investigators is to provide feasible and effective dietary ways for postmenopausal women to improve their vascular function and quality of life. Strawberries are a rich source of bioactive compounds and its total antioxidant content ranks third among all fruits and vegetables. Hence, the purpose of this study is to bring forth evidence that incorporation of strawberries into the diet will reduce blood pressure and improve cardiovascular function in pre- and stage 1-hypertensive postmenopausal women. Sixty eligible postmenopausal women between the ages of 45 and 65 and a seated BP of ≥ 130/85 mm Hg but ≤ 160/100 mmHg at the screening visit will be randomly assigned to one of three groups:
- 1.25 g freeze-dried strawberry powder;
- 2.50 g freeze-dried strawberry powder; or
- 3.placebo powder. Participants will be asked to consume the supplements for 8-weeks. Medical history, medication use, dietary intake, and physical activity will be assessed at 0-, 4-, and 8-weeks followed by blood draw. Serum levels of markers of cardiovascular function as well as oxidative stress and inflammation will be measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Feb 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 26, 2014
CompletedFirst Posted
Study publicly available on registry
March 31, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedDecember 16, 2016
December 1, 2016
1.4 years
March 26, 2014
December 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure
By measuring blood pressure variability and baroreflex sensitivity at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).
8 weeks
Secondary Outcomes (4)
Arterial Stiffness
8 weeks
Endothelial function
8 weeks
Oxidative Stress
8 weeks
Inflammation
8 weeks
Study Arms (3)
Control Group
PLACEBO COMPARATORFreeze-dried placebo powder - two doses of 25 g/day for 8 weeks
25 g of Freeze-dried Strawberry Powder
ACTIVE COMPARATORFreeze-dried strawberry and placebo powder - one dose of 25 g/day of each for 8 weeks
50 g of Freeze-dried Strawberry Powder
EXPERIMENTALFreeze-dried strawberry powder - two doses of 25 g/day for 8 weeks
Interventions
Participants will be given one packet of 25 g of freeze-dried strawberry powder and one packet of 25 g of placebo powder and asked to consume one packet in the morning and one at night.
Participants will be given two packets of 25 g of freeze-dried strawberry powder and asked to consume one packet in the morning and one at night.
Participants will be given two packets of 25 g of placebo powder and asked to consume one packet in the morning and one at night.
Eligibility Criteria
You may qualify if:
- Postmenopausal women (1 to 10 years after natural menopause or bilateral oophorectomy)
- years of age
- Seated blood pressure ≥ 130/85 mm Hg but ≤ 160/100 mm Hg
- BMI \> 25 but \< 40 kg/m2
You may not qualify if:
- Seated blood pressure ≤ 129/84 or ≥160/101 mmHg
- Type I Diabetes
- Cardiovascular disease
- Active cancer
- Glaucoma
- Thyroid disease
- Kidney disease
- Liver disease
- Pancreatic disease
- Enrollment in a weight loss program
- Heavy smokers (\>20 cigarettes per day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- California Strawberry Commissioncollaborator
Study Sites (1)
Florida State University
Tallahassee, Florida, 32306, United States
Related Publications (1)
Feresin RG, Johnson SA, Pourafshar S, Campbell JC, Jaime SJ, Navaei N, Elam ML, Akhavan NS, Alvarez-Alvarado S, Tenenbaum G, Brummel-Smith K, Salazar G, Figueroa A, Arjmandi BH. Impact of daily strawberry consumption on blood pressure and arterial stiffness in pre- and stage 1-hypertensive postmenopausal women: a randomized controlled trial. Food Funct. 2017 Nov 15;8(11):4139-4149. doi: 10.1039/c7fo01183k.
PMID: 29099521DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Bahram H Arjmandi, PhD, RD
Florida State University
- PRINCIPAL INVESTIGATOR
Arturo Figueroa, PhD
Florida State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Margaret A. Sitton Professor and Director of the Center for Advancing Exercise and Nutrition Research on Aging
Study Record Dates
First Submitted
March 26, 2014
First Posted
March 31, 2014
Study Start
February 1, 2013
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
December 16, 2016
Record last verified: 2016-12